CBD for social phobia: what studies say and what has not been compared

CBD for social phobia: what was measured in three small trials, why therapy and SSRIs remain the first choice, and when anxiety requires same-day help.

CBD for social phobia: what was measured in three small trials, why therapy and SSRIs remain the first choice, and when anxiety requires same-day help.

CBD oil without marketing: what is really known about absorption, dosing, drug interactions, quality, and the Polish THC threshold. With sources and dates.

What is CBD, how does it affect the body, what properties are confirmed by research, what is the THC threshold in Poland, and how to choose the form and dosage of the product.

Sublingually, orally, inhaled, or topically? What is really known about the bioavailability of CBD, how long the effect lasts for each method, and which mistakes spoil the result.

Over 65 molecular targets, with influence through the endocannabinoid system considered unlikely. The mechanism of CBD is solely based on measured data.

CBD and ADHD without promises: the only randomized trial did not achieve the primary endpoint, and data on anxiety and sleep come from outside ADHD. What this implies.

Does CBD alleviate allergy symptoms? We check mast cells, Th2 cytokines, drug interactions, and safety based on clinical and preclinical studies.

Cochrane, IASP, and meta-analyses on cannabinoids in chronic pain: what has been proven, what has not, and why the benefits may not outweigh the harms.

CBD and endometriosis: what studies on tissues and animals have shown, what a survey of 484 women really says, and why ESHRE does not mention cannabinoids.

Medical marijuana and CBD in Poland: what studies say about effectiveness and risk, what a Rpw prescription looks like, and where the legal boundary of 0.3 percent THC lies.




Are you over 18 years old?
Book with you